Pnc Financial Services »

Sionna Therapeutics shares owned by Pnc Financial Services

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Pnc Financial Services from 13F filings

Historical chart of Pnc Financial Services investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Pnc Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Pnc Financial Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $147 5 29.40

More positions owned by Pnc Financial Services

Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Et (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Erie Indty Cl A (ERIE)
Amazon (AMZN)
Ishares Tr Rus 1000 Grw E (IWF)
Ishares Tr Core Msci Eafe (IEFA)
Wisdomtree Tr Us Qtly Div Gr (DGRW)

View all positions for Pnc Financial Services

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Atlas Venture Life Science Advisors
Viking Global Investors
Enavate Sciences GP
Jpmorgan Chase & Co
Perceptive Advisors
Vanguard Group
Jennison Associates
Deerfield Management Company
Standard Life Aberdeen
BlackRock
Soleus Capital Management
Baker Bros. Advisors

View all funds holding Sionna Therapeutics